[
    {
        "text": "substance: Benzo[a]pyrene\n(BaP) | type_of_trv: Inhalation TC | trv_value: 2.0E-06\nmg/m3 | study_details: Study Type: developmental\nSpecies: F344 rats (pregnant females)\nMode of Administration: inhalation\n(nose only)\nExposure Regime: 0 (\u201csham\u201d carbon\nblack or unexposed), 25, 75, and\n100 \u00b5g/m3, 4 hours per day for 10 days\n(gestation days 11 to 20)\nDuration: 10 days (gestation days 11-20)\nUncertainty Factors: 3000 (3 for\ntoxicodynamic differences, 10 for\nintraspecies variability, 10 for LOAEL\nto NOAEL extrapolation, and 10\nfor database deficiencies) | threshold_non_threshold_endpoint: LOAEL =\n0.025 mg/m3 | trv_derivation_method: LOAEL adjusted for\ncontinuous daily exposure\nand converted to a human\nequivalent concentration\nbased on a regional\ndeposited dose ratio for\nextrarespiratory effects\nLOAEL =\nHEC\n0.0046 mg/m3\nRfC = LOAEL /UF\nHEC | critical_effect_s: Developmental\ntoxicity\n(decreased\nembryo/foetal\nsurvival) | carcinogenicity_classification: CEPA: Group II\nprobably\ncarcinogenic\nto humans\n(EC and HC, 1994a)\nIARC: Group 1\ncarcinogenic\nto humans\n(IARC, 2012b)\nUS EPA\ncarcinogenic\nto humans\n(US EPA, 2017) | source: US EPA, 2017\n(based on\nArchibong et al.,\n2002)",
        "metadata": {
            "table_name": "output_table26",
            "page": 26,
            "columns": [
                "substance",
                "type_of_trv",
                "trv_value",
                "study_details",
                "threshold_non_threshold_endpoint",
                "trv_derivation_method",
                "critical_effect_s",
                "carcinogenicity_classification",
                "source"
            ]
        }
    },
    {
        "text": "substance: Benzo[a]pyrene\n(BaP) | type_of_trv: Oral SF | trv_value: 1.289E+00\n(mg/kg -day) \u20131\nBW | study_details: Study Type: chronic\nSpecies: B6C3F1 female mice\nMode of Administration: diet\nExposure Regime: 0, 5, 25, and 100 ppm\n(corresponding to approximately 0, 0.7,\n3.3, and 13.0 mg/kg -day, as per HC,\nBW\n2016a)\nDuration: 2 years\nUncertainty Factors: N/A | threshold_non_threshold_endpoint: BMDL =\n10\n0.5389 mg/kg -day\nBW | trv_derivation_method: Allometric scaling of\nthe BMDL (to account\n10\nfor interspecies variability\nand derive a human\nequivalent value)\nBMDL =\n10, HEC\n0.07758 mg/kg -day\nBW\nOral SF =\n0.1/BMDL\n10, HEC\nwhere 0.1 = 10% extra\ncancer risk | critical_effect_s: Digestive\ntract toxicity\n(tumours of the\nforestomach) | source: HC, 2016a\n(based on\nCulp et al., 1998\nand Moffat et al.,\n2015)",
        "metadata": {
            "table_name": "output_table26",
            "page": 26,
            "columns": [
                "substance",
                "type_of_trv",
                "trv_value",
                "study_details",
                "threshold_non_threshold_endpoint",
                "trv_derivation_method",
                "critical_effect_s",
                "carcinogenicity_classification",
                "source"
            ]
        }
    },
    {
        "text": "substance: Benzo[a]pyrene\n(BaP) | type_of_trv: Inhalation UR | trv_value: 6.0E-01\n(mg/m3)\u20131 | study_details: Study Type: chronic\nSpecies: Syrian golden male hamsters\nMode of Administration: inhalation\n(nose only) of benzo[a]pyrene condensed\nonto sodium chloride aerosols\nExposure Regime: 2.2, 9.5, and\n46.5 mg BaP/m3 (time-weighted average\nconcentrations of 0, 0.25, 1.01, and\n4.29 mg/m3, corresponding to 0, 2,\n10, and 50 mg/m3 nominal study\nconcentrations), 4.5 hours/day for\nthe first 10 weeks, then 3 hours/day\nfor the remainder of the study\nDuration: minimum of 10 weeks up\nto 130 weeks\nUncertainty Factors: N/A | threshold_non_threshold_endpoint: BMCL =\n10\n0.16 mg/m3 | trv_derivation_method: Multistage Weibull\ntime-to-tumour\ndose-response model\n+\nLinear extrapolation from\nthe POD associated with\n10% extra cancer risk\nInhalation UR =\n0.1/BMCL\n10\nwhere 0.1 is 10% extra\ncancer risk | critical_effect_s: Cancer\n(tumours of\nthe upper\ngastrointestinal\ntract and upper\nrespiratory tract\n[squamous cell\nneoplasia in the\nlarynx, pharynx,\ntrachea, nasal\ncavity, esophagus,\nand forestomach]) | source: US EPA, 2017\n(based on\nThyssen et al.,\n1981)",
        "metadata": {
            "table_name": "output_table26",
            "page": 26,
            "columns": [
                "substance",
                "type_of_trv",
                "trv_value",
                "study_details",
                "threshold_non_threshold_endpoint",
                "trv_derivation_method",
                "critical_effect_s",
                "carcinogenicity_classification",
                "source"
            ]
        }
    }
]